Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: July 8, 2002
Last updated: December 18, 2013
Last verified: May 2007